ROSEN, SKILLED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX — Neutral
PCRX Accesswire — February 10, 2025NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / WHY: New York, N.Y., February 10, 2025.
Lattice Semiconductor Corporation (LSCC) Q4 2024 Earnings Call Transcript — Neutral
LSCC Seeking Alpha — February 10, 2025Lattice Semiconductor Corporation (NASDAQ:LSCC ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Rick Muscha - Senior Director of IR Ford Tamer - CEO Tonya Stevens - Chief Accounting Officer and Former Interim CFO Lorenzo Flores - CFO Conference Call Participants Melissa Weathers - Deutsche Bank David Williams - The Benchmark Company Ruben Roy - Stifel Nick Doyle - Needham and Company Duksan Jang - Bank of America Joshua Buchalter - TD Cowen Srini Pajjuri - Raymond James Quinn Bolton - Needham and Company Operator Greetings and welcome to the Lattice Semiconductor Fourth Quarter Fiscal …
Harmonic Inc. (HLIT) Q4 2024 Earnings Call Transcript — Neutral
HLIT Seeking Alpha — February 10, 2025Harmonic Inc. (NASDAQ:HLIT ) Q4 2024 Results Conference Call February 10, 2025 5:00 PM ET Company Participants David Hanover - Investor Relations Nimrod Ben-Natan - President & Chief Executive Officer Walter Jankovic - Chief Financial Officer Conference Call Participants Simon Leopold - Raymond James Ryan Koontz - Needham Steven Frankel - Rosenblatt Securities Tim Savageaux - Northland Capital Markets Operator Welcome to the Fourth Quarter and Full Year 2024 Harmonic Earnings Conference Call. My name is Victor, and I will be your operator for today's call.
Levi & Korsinsky Notifies Crocs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CROX — Neutral
CROX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=128552&wire=1 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by February 24, 2025 Deadline to Join Class Action Against Transocean Ltd. (RIG) — Neutral
RIG Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=128548&wire=1 or contact Joseph E.
Levi & Korsinsky Announces an Investigation on Behalf of GeneDx Holdings Corp. (WGS) Shareholders Who May Have Been Affected by Fraud — Neutral
WGS Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerning possible violations of federal securities laws. Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud".
Shareholders that lost money on Regeneron Pharmaceuticals, Inc.(REGN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
REGN Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=128551&wire=1 or contact Joseph E. Levi, Esq.
Novo Nordisk A/S Class Action: Levi & Korsinsky Reminds Novo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - NVO — Neutral
NVO Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128553&wire=1 or contact Joseph E. Levi, Esq.
Kirby McInerney LLP Announces Investigation Against Semtech Corporation (SMTC) on Behalf of Investors — Neutral
SMTC GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Semtech Corporation (“Semtech” or the “Company”) (NASDAQ:SMTC). The investigation concerns whether Semtech and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
Franklin Covey's stock continues to lag, with the market overfocused on their near-term transition and undervaluing long-term growth. By and large, demand continues to remain stable, indicating prior macro headwinds are behind them. With a clear runway for continued salesperson growth, sales and EBITDA should materially grow over the next 4 years, producing what I believe to be an attractive IRR.
Apple and Google take down malicious apps from their app stores — Neutral
AAPL GOOG GOOGL TechCrunch — February 10, 2025Apple and Google have pulled as many as 20 apps from their respective app stores after security researchers found the apps were carrying data-stealing malware for almost a year.
Bank of America: Corporate Sentiment Reaches Highest Level Since 2004 — Positive
BAC PYMNTS — February 10, 2025Bank of America's Corporate Sentiment Score reportedly reached its highest level since the bank began recording it in 2004.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca PLC Lawsuit - AZN — Neutral
AZN Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=128546&wire=1 or contact Joseph E. Levi, Esq.
Shareholders that Lost Money on Joint Stock Company Kaspi.kz (KSPI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
KSPI Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=128545&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Newmont Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 1, 2025 - NEM — Neutral
NEM Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=128544&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Nextracker Inc. (NXT) Shareholders — Neutral
NXT Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=128547&wire=1 or contact Joseph E. Levi, Esq.
Investor Alert: Robbins LLP Informs Investors of the Neumora Therapeutics, Inc. Class Action — Neutral
NMRA PRNewsWire — February 10, 2025SAN DIEGO , Feb. 10, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired Neumora Therapeutics, Inc. (NASDAQ: NMRA) common stock pursuant to the Offering Documents issued in connection with the Company's initial public offering ("IPO") on September 15, 2023. Neumora is a clinical-stage biopharmaceutical company.
Compass Minerals (CMP) Reports Q1 Loss, Tops Revenue Estimates — Negative
CMP Zacks Investment Research — February 10, 2025Compass Minerals (CMP) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $0.05 per share a year ago.
Cybersecurity ETF (BUG) Hits New 52-Week High — Positive
BUG Zacks Investment Research — February 10, 2025For investors seeking momentum, Global X Cybersecurity ETF BUG is probably on the radar. The fund just hit a 52-week high and is up 35.77% from its 52-week low price of $26.03/share.
Watts Water (WTS) Reports Q4 Earnings: What Key Metrics Have to Say — Positive
WTS Zacks Investment Research — February 10, 2025Although the revenue and EPS for Watts Water (WTS) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.